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The dorC gene of the dimethyl sulfoxide respiratory
(dor) operon of Rhodobacter capsulatus encodes a pen-
taheme c-type cytochrome that is involved in electron
transfer from ubiquinol to periplasmic dimethyl sulfox-
ide reductase. DorC was expressed as a C-terminal fu-
sion to an 8-amino acid FLAG epitope and was purified
from detergent-solubilized membranes by ion exchange
chromatography and immunoaffinity chromatography.
The DorC protein had a subunit Mr 5 46,000, and pyri-
dine hemochrome analysis indicated that it contained 5
mol heme c/mol DorC polypeptide, as predicted from the
derived amino acid sequence of the dorC gene. The re-
duced form of DorC exhibited visible absorption max-
ima at 551.5 nm (a-band), 522 nm (b-band), and 419 nm
(Soret band). Redox potentiometry of the heme centers
of DorC identified five components (n 5 1) with mid-
point potentials of 234, 2128, 2184, 2185, and 2276 mV.
Despite the low redox potentials of the heme centers,
DorC was reduced by duroquinol and was oxidized by
dimethyl sulfoxide reductase.
The ability to use Me2SO and trimethylamine-N-oxide
(TMAO)1 as electron acceptors is widespread among facultative
aerobic bacteria and the organization of the Me2SO and TMAO
respiratory chains is now well defined (1). In the Me2SO res-
piratory system of purple photosynthetic bacteria such as
Rhodobacter capsulatus, electrons are transferred from pri-
mary dehydrogenases via the ubiquinone pool to a periplasmic
Me2SO reductase (2). Recent sequence and mutational analysis
of the Me2SO respiratory gene cluster from photosynthetic
bacteria has identified a pentaheme c-type cytochrome (DorC)
as the likely mediator of electron transfer from ubiquinol to
Me2SO reductase (3).
2 The TMAO respiratory (Tor) system of
Escherichia coli (5) is very similar to the Dor system of R.
capsulatus, and they differ from the Me2SO respiratory (Dms)
system of E. coli. The Me2SO reductase (DmsABC) of E. coli can
be purified as a menaquinol-oxidizing Me2SO reductase com-
plex that lacks c-type cytochromes (6). Me2SO reductase from
R. capsulatus has been purified as a monomeric protein con-
taining a pterin molybdenum cofactor (Moco) as its only pros-
thetic group (7). This property of Me2SO reductase has many
advantages for spectroscopic characterization of Moco, but a
major deficiency has been the lack of a physiologically relevant
electron donor. To overcome this problem we describe in this
paper the purification and characterization of DorC.
The derived amino acid sequence of Rhodobacter DorC indi-
cated that it was related to members of the NirT class of
tetraheme c-type cytochromes (3).2 However, DorC is predicted
to be a pentaheme cytochrome with a fifth c-type heme binding
motif in the C-terminal polypeptide, which is absent from the
tetraheme members of the NirT class. Almost all of the mem-
bers of the NirT class are involved in an anaerobic respiratory
pathway, and their role appears to be to catalyze electron
transfer from the Q-pool to a periplasmic terminal reductase
(8). Although molecular genetic studies have provided an in-
sight into the function and likely properties of cytochromes of
the NirT class, very little is known about their biochemical and
spectroscopic properties.
EXPERIMENTAL PROCEDURES
Expression and Purification of DorC—A 1.4-kilobase DNA fragment
containing the complete dorC nucleotide sequence except for the stop
codon and including the upstream regulatory sequences of the dor
operon was amplified by polymerase chain reaction using plasmid
pALS3 as a template.2 The forward primer was designed so that a
BamHI site would be synthesized while the reverse primer directed the
synthesis of an EcoRI site plus a sequence to include a C-terminal
8-amino acid FLAG epitope (9). The 1.4-kilobase polymerase chain
reaction product was cloned into pDSK519 (10) to create plasmid
pALS300. pALS300 was transferred from E. coli S17–1 to R. capsulatus
37b4 by conjugation (11).
DorC was expressed in 2l R. capsulatus cells grown for 24 h under
phototrophic conditions in RCV medium (12) in the presence of 60 mM
Me2SO. Membranes were prepared from the cells using a French Press
as in Ref. 2 and were resuspended in Tris-buffered saline. Proteins were
solubilized by treatment of membranes with 4% Triton X-100 for 90 min
at room temperature. The mixture was then centrifuged (145,000 3 g,
90 min, 4 °C), and the soluble fraction was collected. The soluble frac-
tion containing DorC (containing approximately 100 mg of protein) was
dialyzed against 50 mM Tris-HCl, pH 8.0, 0.2% Triton X-100 and then
charged onto a DEAE-Trisacryl column (bed volume, 15 ml), equili-
brated with the same buffer. DorC was eluted using a 100-ml linear
gradient of NaCl from 0 to 1 M. The DorC-enriched fraction from the
anion exchange chromatography was dialyzed against Tris-buffered
saline plus 0.2% Triton X-100 and then charged onto a 2-ml column
containing FLAG affinity resin (Eastman Kodak). Bound DorC was
eluted with 0.1 M glycine, pH 3.5, 0.2% Triton X-100. 2-ml fractions
were collected, and the pH was immediately raised by addition of 50 ml
1 M Tris-HCl, pH 8.0.
Spectroscopy and Redox Potentiometry—Optical spectra of DorC
were collected using a Hitachi U-3000 spectrophotometer. Pyridine
hemochrome analysis of DorC was carried out according to the method
of Berry and Trumpower (13). For reduction of DorC with duroquinol,
the cytochrome was incubated with 2 units ml21 Clostridial diaphorase,
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25 mM duroquinone and 200 mM NADH. Redox potentiometry of DorC
was performed by the method of Dutton (14). Absorption spectra were
recorded between 500 and 600 nm using a Jasco 7850 UV-visible spec-
trophotometer. Redox titrations were performed with dithionite as re-
ductant and ferricyanide as oxidant in the presence of the following
mediators: 2.5 mM benzoquinone (Eo9 5 1280 mV), 2.5 mM 1,2-naphtho-
quinone (Eo9 5 1145 mV), 2.5 mM 1,4-naphthoquinone (Eo9 5 160 mV),
20 mM duroquinone (Eo9 5 15 mV), 20 mM 1,4-dihydroxynaphthoqui-
none (Eo9 5 2145 mV), 5 mM anthroquinone-2-sulfonate (Eo9 5 2225
mV), and 5 mM benzylviologen (Eo9 5 2350 mV). The absorbance change
at 551.5–540 nm was plotted against redox potential, and theoretical
Nernstian curves were fitted to the data using Sigma Plot.
Protein Methods—SDS-PAGE analysis of proteins and Western blot-
ting using an anti-FLAG antibody were performed as in Refs. 15 and 16.
Protein concentration was determined as in Ref. 17.
RESULTS
Expression and Purification of DorC—A plasmid for the ex-
pression of DorC with an 8-amino acid FLAG epitope attached
to the C terminus was constructed as described under “Exper-
imental Procedures.” This plasmid was expressed in R. capsu-
latus cells grown phototrophically in the presence of Me2SO.
Membrane and soluble fractions were prepared, and produc-
tion of DorC was monitored by Western blotting. A single
immunoreactive polypeptide with a molecular mass of 46 kDa
was observed; this was the expected size of the DorC-FLAG
polypeptide (data not shown). The putative DorC polypeptide
was located exclusively in the membrane fraction. Several de-
tergents were tested for their ability to solubilize DorC. Triton
X-100 proved to be the most efficient, but even this detergent
failed to completely solubilize DorC because an immunoreac-
tive polypeptide could still be detected in the detergent-insol-
uble membrane fraction.
The detergent-solubilized fraction was applied to a DEAE-
Trisacryl anion exchange column. DorC was eluted from the
column at about 450 mM NaCl. The fractions containing DorC
were then applied to a FLAG-affinity resin and eluted as de-
scribed under “Experimental Procedures.” The pooled fractions
containing the colored cytochrome were analyzed by SDS-
PAGE. Fig. 1 shows the presence of a single polypeptide Mr 5
46,000 corresponding to DorC. This protein cross-reacted with
the anti-FLAG antibody in Western blots and stained for heme-
dependent peroxidase activity (data not shown), confirming
that the DorC-FLAG polypeptide had been purified.
Optical Spectroscopy of DorC—Fig. 2 shows a dithionite-
reduced minus ferricyanide-oxidized spectrum of DorC. Ab-
sorption peaks at 551.5 nm (a-band), 522 nm (b-band), and 419
FIG. 1. Coomassie-stained SDS-PAGE gel of purified DorC.
Lane 1, molecular mass markers; lane 2, 8 mg of purified DorC.
FIG. 2. Dithionite reduced minus ferricyanide oxidized differ-
ence spectrum of DorC.
FIG. 3. Pyridine hemochrome (A) and pyridine hemichrome
(B) spectra of DorC.
FIG. 4. Redox potentiometry of DorC (12 mM). Symbols represent
the results of two separate titrations. The solid line is a theoretical
curve generated using the Nernst equation for five n 5 1 oxidation-
reduction processes with midpoint redox potentials 234, 2128, 2184,
2185, and 2276 mV with relative contributions to the total absorbance
signal of 10, 22, 15, 30, and 23%, respectively.
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nm (Soret band) were typical of a reduced cytochrome. The
absorption minimum at 408 nm represents the Soret absorp-
tion band of the oxidized form of DorC. A spectrum of the
resting form of DorC exhibited this 408 nm peak, and the
absence of the a-band and b-band of the reduced cytochrome
indicates that the DorC, as prepared, is in a fully oxidized
state.
The number of heme groups per DorC polypeptide was de-
termined by pyridine hemochrome analysis. Fig. 3 shows
hemichrome and hemochrome spectra of DorC in alkaline pyr-
idine. The presence of an absorption maximum at 550 nm in
the pyridine hemochrome spectrum (Fig. 3) confirmed that
DorC contained only c-type hemes. Using the method of Berry
and Trumpower (13), it was calculated that there were 4.9 mol
c-type heme/mol DorC. This confirms that DorC is a penta-
heme, as indicated from the primary structure analysis.2
Determination of the Midpoint Redox Potential of the Heme
Centers of DorC—The thermodynamic properties of the heme
centers in DorC were analyzed by redox potentiometry. It was
observed that during reductive titration no reduction of the
cytochrome was seen until the ambient redox potential (at pH
7.0) was below 0 mV. This is consistent with the observation
that sodium ascorbate (Em 5 165 mV) did not reduce DorC as
seen in reduced minus oxidized difference spectra (data not
shown). Fig. 4 shows the change in absorbance of the a band
(551.5 nm minus 540 nm as the reference wavelength) of DorC
as a function of the ambient redox potential. The data obtained
could be fitted to a five-component Nernstian curve (n 5 1) with
midpoint potentials (Em7.0) of 234 6 2, 2128 6 2, 2184 6 3,
2185 6 3, and 2276 6 3 mV.
DorC-dependent Electron Transfer from Duroquinol to
Me2SO Reductase—DorC is the only protein encoded by the dor
operon that could act as a mediator of electron transfer be-
tween ubiquinol and Me2SO reductase.
2 Before reconstitution
of this electron transfer pathway was attempted, the ability of
duroquinol to reduce DorC was investigated. A duroquinol-
reduced spectrum of DorC indicated that at least some of the
heme centers of the protein had been reduced (data not shown).
For the reconstitution of electron transfer from quinol to
Me2SO reductase DorC was titrated with an approximately
stoichiometric amount of duroquinol under anaerobic condi-
tions. This led to an increase in absorbance at 551.5 nm (Fig. 5).
Upon addition of Me2SO reductase there was a decrease in the
absorption of the a-band of DorC (Fig. 5), indicating that elec-
tron transfer from DorC to Me2SO reductase had occurred.
Control experiments showed that the oxidation of DorC was
specifically dependent upon Me2SO reductase.
DISCUSSION
DorC from R. capsulatus is the first pentaheme cytochrome
in the NirT class to be purified and characterized. The presence
of photosynthetic pigments in the membrane of R. capsulatus
made the detection of the native cytochrome very difficult and
necessitated the strategy of attaching a FLAG peptide as a tag
for detection and affinity purification. The protein was purified
from R. capsulatus because all of our attempts to express DorC
in E. coli were unsuccessful.3 DorC was located exclusively in
the membrane of R. capsulatus, and this would be consistent
with a role in ubiquinol oxidation. In vivo, it is expected that
DorC would be a peripheral membrane protein anchored to the
membrane by its hydrophobic N terminus, and this explains
why detergents were required to solubilize the protein.
The optical spectroscopy of DorC identified an absorption
maximum at 551.5 nm for the a-band. This is a symmetrical
peak with very little complexity, and it suggests that although
the midpoint redox potentials of the heme centers differ, it is
likely that each possesses the same fifth and sixth ligands.
There was no evidence for high spin five coordinate heme with
3 A. L. Shaw and A. G. McEwan, unpublished observations.
FIG. 5. A, increase in the absorbance of
the a-band of DorC with time (0–14 min)
upon incubation of 8.0 m M DorC in 20 m M
HEPES-NaOH, pH 7.2, 1 m M EDTA,
0.1% Triton X-100 with 2 units ml21 dia-
phorase, 20 mM NADH, and 10 mM duro-
quinone. At time 15 min, 3 mM Me2SO
reductase was added to the reduced DorC,
and the decrease in the absorbance of the
a-band was measured from time 16 min.
B, increase in absorbance at 551.5 nm
against time. C, decrease in absorbance at
551.5 nm against time.
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an optical band beyond 600 nm as seen in cytochrome c9 for
example (18). Redox potentiometry was consistent with the
presence five heme centers, all of which have midpoint redox
potentials below 0 mV. These are surprisingly low values for a
protein that is thought to act as an electron acceptor from
ubiquinol because the Eo9 for the ubiquinol/ubiquinone redox
couple is 140 mV (19). However, it was observed that water-
soluble duroquinol could reduce DorC. The thermodynamic
quantity described in this paper is the “macroscopic” potential
of the heme centers of DorC (20, 21). These parameters are not
influenced by electron/electron cooperativity between heme
centers. However, it has been shown that in the tetraheme
cytochrome c3 from Desulfovibrio vulgaris each heme redox
potential is dependent on the oxidation state of the other three
hemes (22), and this can affect the thermodynamic properties
of a multi-heme protein (21). This can lead to a variety of
potential microscopic heme-heme interacting potentials that
may be higher than the macroscopic potentials. The ability of
DorC to be reduced by duroquinol can be rationalized if the
heme with the highest potential (234 mV) is reducible by
duroquinol. Under physiological conditions this would suggest
that the DorC protein would be reduced when the Eh of the
ubiquinol/ubiquinone pool was lower than the Eo9 for the
ubiquinol/ubiquinone redox couple. Such a situation could oc-
cur under phototrophic (anaerobic) conditions in the presence
of reduced carbon sources (23). Further work to demonstrate
and analyze heme-heme interactions in DorC using EPR and/or
NMR spectroscopy is now required.
There has been intense interest in the structure and mech-
anism of Me2SO reductase (4, 24, 25), and many questions
remain regarding the route of electron transfer to the molyb-
denum atom. It seems almost certain that one of the molyb-
dopterin guanine dinucleotide moieties of Moco will act as a
conduit for electrons from DorC. The purification of DorC that
we have described opens the way for experiments to look at
electron transfer to Me2SO reductase using the physiological
electron donor. This may help resolve some current controver-
sies relating to the mechanism of Me2SO reductase by avoiding
the need to use dithionite and viologens as electron donors.
Although we showed that DorC was reduced by duroquinol and
that reduced DorC was oxidized by Me2SO reductase, it was
not possible to use DorC to catalyze steady state electron trans-
fer between duroquinol and Me2SO reductase. The reason is
that Me2SO reductase itself exhibited duroquinol-Me2SO oxi-
doreductase activity.3 However, under physiological conditions
DorC would be required for the oxidation of ubiquinol-10,
which, unlike water-soluble duroquinol, is buried within the
hydrophobic domain of the cytoplasmic membrane and thus is
inaccessible to periplasmic Me2SO reductase.
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